Role of RAS Mutation Status as a Prognostic Factor for Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy Based on Fluoropyrimidines and Oxaliplatin, With or Without Bevavizumab: A Retrospective Analysis

Molecular and Clinical Oncology- United Kingdom

doi 10.3892/mco.2017.1149

Full Text

Abstract

Available in

Date

February 3, 2017

Authors

Javier Garde Noguera

Eloisa Jantus-Lewintre

Mireia Gil-Raga

Elena Evgenyeva

Sonia Maciá Escalante

Antonio Llombart-Cussac

Carlos Camps Herrero

Publisher

Spandidos Publications

Related search

PML as a Potential Predictive Factor of Oxaliplatin/Fluoropyrimidine-Based First Line Chemotherapy Efficacy in Colorectal Cancer Patients

Journal of Cellular Physiology

Clinical Biochemistry

Cell Biology

Physiology

2011

English

Oxaliplatin, 5-Fluorouracil and Leucovorin (Modified FOLFOX-6) as First-Line Chemotherapy for Advanced Gastric Cancer Patients With Poor Performance Status

English

Gemcitabine Combined With Capecitabine Compared to Gemcitabine With or Without Erlotinib as First-Line Chemotherapy in Patients With Advanced Pancreatic Cancer

Cancer Research and Treatment

Cancer Research

Oncology

2014

English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)

Dentistry

2011

English

Combination Therapy With Docetaxel and S-1 as a First-Line Treatment in Patients With Advanced or Recurrent Gastric Cancer: A Retrospective Analysis

World Journal of Surgical Oncology

Surgery

Oncology

2010

English

Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy

Oncotarget

Oncology

2017

English

Clinical Efficacy and Safety of Nimotuzumab Plus Chemotherapy in Patients With Advanced Colorectal Cancer: A Retrospective Analysis

Journal of International Medical Research

English

Significance of Serum Ferritin as a Prognostic Factor in Advanced Hepatobiliary Cancer Patients Treated With Korean Medicine: A Retrospective Cohort Study

BMC Complementary and Alternative Medicine

English

First-Line Single-Agent Chemotherapy for Patients With Recurrent or Metastatic Gastric Cancer With Poor Performance Status

Experimental and Therapeutic Medicine

English

Amanote Research

Role of RAS Mutation Status as a Prognostic Factor for Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy Based on Fluoropyrimidines and Oxaliplatin, With or Without Bevavizumab: A Retrospective Analysis

Molecular and Clinical Oncology- United Kingdom

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

PML as a Potential Predictive Factor of Oxaliplatin/Fluoropyrimidine-Based First Line Chemotherapy Efficacy in Colorectal Cancer Patients

Oxaliplatin, 5-Fluorouracil and Leucovorin (Modified FOLFOX-6) as First-Line Chemotherapy for Advanced Gastric Cancer Patients With Poor Performance Status

Gemcitabine Combined With Capecitabine Compared to Gemcitabine With or Without Erlotinib as First-Line Chemotherapy in Patients With Advanced Pancreatic Cancer

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Combination Therapy With Docetaxel and S-1 as a First-Line Treatment in Patients With Advanced or Recurrent Gastric Cancer: A Retrospective Analysis

Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy

Clinical Efficacy and Safety of Nimotuzumab Plus Chemotherapy in Patients With Advanced Colorectal Cancer: A Retrospective Analysis

Significance of Serum Ferritin as a Prognostic Factor in Advanced Hepatobiliary Cancer Patients Treated With Korean Medicine: A Retrospective Cohort Study

First-Line Single-Agent Chemotherapy for Patients With Recurrent or Metastatic Gastric Cancer With Poor Performance Status